Celldex Therapeutics Inc (CLDX) — Cash Flow Reinvestment Rate

Latest as of December 2008: 0.02x

Celldex Therapeutics Inc (CLDX) has a Cash Flow Reinvestment Rate of 0.02x as of December 2008, reinvesting $26.75K (capex $26.75K ) from operating cash flow of $1.29 Million. Check Celldex Therapeutics Inc (CLDX) cash flow quality to evaluate the quality of earnings relative to operating cash generation.

Reinvestment Rate

0.02x
(Capex + Investments) / Operating CF

Total Reinvested

$26.75K
Capex + Investments

Operating Cash Flow

$1.29 Million
USD

Capital Expenditures

$26.75K
USD

Celldex Therapeutics Inc Cash Flow Reinvestment Rate (1986–2008)

Historical reinvestment intensity for Celldex Therapeutics Inc across 3 annual periods. Explore Celldex Therapeutics Inc long-term investment allocation to see how much of total assets are deployed in long-term investments.

Annual Cash Flow Reinvestment Rate for Celldex Therapeutics Inc (1986–2008)

Year-by-year capital reinvestment analysis for Celldex Therapeutics Inc. For live market cap and broader valuation context, see how much is Celldex Therapeutics Inc worth.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2008 0.07x $1.30 Million $18.28 Million $1.30 Million ▼ -79.3%
2006 0.35x $9.32 Million $27.00 Million $9.32 Million
1986 0.00x $0.00 $12.30 Million $0.00
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow